Population Sciences Branch, NHLBI/NHI, Bethesda, MD, USA.
Framingham Heart Study, Framingham, MA, USA.
Hum Genet. 2018 Mar;137(3):203-213. doi: 10.1007/s00439-018-1873-4. Epub 2018 Feb 8.
Increasing evidence implicates mitochondrial dysfunction in aging and age-related conditions. But little is known about the molecular basis for this connection. A possible cause may be mutations in the mitochondrial DNA (mtDNA), which are often heteroplasmic-the joint presence of different alleles at a single locus in the same individual. However, the involvement of mtDNA heteroplasmy in aging and age-related conditions has not been investigated thoroughly. We deep-sequenced the complete mtDNA genomes of 356 Framingham Heart Study participants (52% women, mean age 43, mean coverage 4570-fold), identified 2880 unique mutations and comprehensively annotated them by MITOMAP and PolyPhen-2. We discovered 11 heteroplasmic "hot" spots [NADH dehydrogenase (ND) subunit 1, 4, 5 and 6 genes, n = 7; cytochrome c oxidase I (COI), n = 2; 16S rRNA, n = 1; D-loop, n = 1] for which the alternative-to-reference allele ratios significantly increased with advancing age (Bonferroni correction p < 0.001). Four of these heteroplasmic mutations in ND and COI genes were predicted to be deleterious nonsynonymous mutations which may have direct impact on ATP production. We confirmed previous findings that healthy individuals carry many low-frequency heteroplasmy mutations with potentially deleterious effects. We hypothesize that the effect of a single deleterious heteroplasmy may be minimal due to a low mutant-to-wildtype allele ratio, whereas the aggregate effects of many deleterious mutations may cause changes in mitochondrial function and contribute to age-related diseases. The identification of age-related mtDNA mutations is an important step to understand the genetic architecture of age-related diseases and may uncover novel therapeutic targets for such diseases.
越来越多的证据表明线粒体功能障碍与衰老和与年龄相关的疾病有关。但是,对于这种联系的分子基础知之甚少。一个可能的原因可能是线粒体 DNA(mtDNA)的突变,这些突变通常是异质性的——即在同一个体的同一个基因座上存在不同等位基因的共同存在。然而,mtDNA 异质性在衰老和与年龄相关的疾病中的参与尚未得到彻底研究。我们对 356 名弗雷明汉心脏研究参与者(52%为女性,平均年龄 43 岁,平均覆盖率 4570 倍)的完整 mtDNA 基因组进行了深度测序,确定了 2880 个独特的突变,并通过 MITOMAP 和 PolyPhen-2 对它们进行了全面注释。我们发现了 11 个异质性“热点”[NADH 脱氢酶(ND)亚基 1、4、5 和 6 基因,n = 7;细胞色素 c 氧化酶 I(COI),n = 2;16S rRNA,n = 1;D-环,n = 1],其中替代等位基因与参考等位基因的比例随着年龄的增长而显著增加(Bonferroni 校正 p < 0.001)。ND 和 COI 基因中的四个异质性突变被预测为具有潜在有害影响的非同义突变。我们证实了先前的发现,即健康个体携带许多具有潜在有害影响的低频异质性突变。我们假设,由于突变等位基因与野生型等位基因的比例较低,单个有害异质性的影响可能很小,而许多有害突变的综合影响可能导致线粒体功能发生变化,并导致与年龄相关的疾病。鉴定与年龄相关的 mtDNA 突变是理解与年龄相关疾病遗传结构的重要步骤,并且可能为这些疾病揭示新的治疗靶点。